Literature DB >> 16923460

Use of complementary therapies in patients with cardiovascular disease.

Gloria Y Yeh1, Roger B Davis, Russell S Phillips.   

Abstract

Previous studies have suggested that patients with chronic medical conditions use complementary and alternative medicine (CAM) at a higher rate than the general population. Despite recent interest in CAM for cardiovascular disease, few data are available regarding patterns of use in patients with cardiovascular disease in the United States. This study used the 2002 National Health Interview Survey and analyzed data on CAM use in 10,572 respondents with cardiovascular disease. Among those with cardiovascular disease, 36% had used CAM (excluding prayer) in the previous 12 months. The most commonly used therapies were herbal products (18%) and mind-body therapies (17%). Among herbs, echinacea, garlic, ginseng, ginkgo biloba, and glucosamine with or without chondroitin were most commonly used. Among mind-body therapies, deep-breathing exercises and meditation were most commonly used. Overall, CAM was used most frequently for musculoskeletal complaints (24% of respondents who used mind-body therapies, 22% who used herbs, 45% who used any CAM). Mind-body therapies were also used for anxiety or depression (23%) and stress or emotional health and wellness (16%). Herbs were commonly used for head and chest colds (22%). Fewer respondents (10%) used CAM specifically for their cardiovascular conditions (5% for hypertension, 2% for coronary disease, 3% for vascular insufficiency, < 1% for heart failure or stroke). Most, however, who used CAM for their cardiovascular condition perceived the therapies to be helpful (80% for herbs, 94% for mind-body therapies). CAM use was more common in younger respondents, women, Asians, and those with more education and greater incomes. In conclusion, CAM use, particularly herbs and mind-body therapies, is common in the United States in patients with cardiovascular disease and mirrors use in the general population. CAM use specifically to treat cardiovascular conditions, however, is less common.

Entities:  

Mesh:

Year:  2006        PMID: 16923460     DOI: 10.1016/j.amjcard.2006.03.051

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  84 in total

1.  Complementary and alternative medicine use among US adults with common neurological conditions.

Authors:  Rebecca Erwin Wells; Russell S Phillips; Steven C Schachter; Ellen P McCarthy
Journal:  J Neurol       Date:  2010-06-11       Impact factor: 4.849

2.  Patterns of mind-body therapies in adults with common neurological conditions.

Authors:  Rebecca Erwin Wells; Russell S Phillips; Ellen P McCarthy
Journal:  Neuroepidemiology       Date:  2010-12-22       Impact factor: 3.282

Review 3.  Roles and mechanisms of ginseng in protecting heart.

Authors:  Si-Dao Zheng; Hong-Jin Wu; De-Lin Wu
Journal:  Chin J Integr Med       Date:  2012-07-07       Impact factor: 1.978

4.  Randomised, double-blind, placebo-controlled, assessment of the efficacy and safety of dietary supplements in prehypertension.

Authors:  F Pelliccia; V Pasceri; G Marazzi; A Arrivi; L Cacciotti; G Pannarale; G Speciale; C Greco; C Gaudio
Journal:  J Hum Hypertens       Date:  2017-04-27       Impact factor: 3.012

5.  Religion and the use of complementary and alternative medicine (CAM) among cardiac patients.

Authors:  Ethel G Nicdao; Amy L Ai
Journal:  J Relig Health       Date:  2014-06

6.  Use of complementary and alternative therapies by overweight and obese adults.

Authors:  Suzanne M Bertisch; Christina C Wee; Ellen P McCarthy
Journal:  Obesity (Silver Spring)       Date:  2008-05-01       Impact factor: 5.002

7.  Ginsenoside Re suppresses electromechanical alternans in cat and human cardiomyocytes.

Authors:  Y G Wang; A V Zima; X Ji; R Pabbidi; L A Blatter; S L Lipsius
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

8.  The prevalence and correlates of mind-body therapy practices in patients with acute coronary syndrome.

Authors:  Yvonne W Leung; Hala Tamim; Donna E Stewart; Heather M Arthur; Sherry L Grace
Journal:  Complement Ther Med       Date:  2008-10       Impact factor: 2.446

9.  Dark chocolate or tomato extract for prehypertension: a randomised controlled trial.

Authors:  Karin Ried; Oliver R Frank; Nigel P Stocks
Journal:  BMC Complement Altern Med       Date:  2009-07-08       Impact factor: 3.659

10.  Evaluation of prescribing patterns in a German network of CAM physicians for the treatment of patients with hypertension: a prospective observational study.

Authors:  Elke Jeschke; Thomas Ostermann; Horst C Vollmar; Matthias Kröz; Angelina Bockelbrink; Claudia M Witt; Stefan N Willich; Harald Matthes
Journal:  BMC Fam Pract       Date:  2009-12-10       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.